Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 2/20 | 0.48 |
| ▸ | BCR | P11274 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | CASP3 | P42574 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14253104 | 0.91 | LTA4H (0.50) | ABL1BCRALDH1A1KDM4EMAPT | |
| SCHEMBL867469 | 0.91 | LTA4H (0.50) | ABL1BCRALDH1A1KDM4EMAPT | |
| SCHEMBL15591131 | 0.90 | LTA4H (0.48) | ABL1BCRALDH1A1KDM4EMAPT | |
| SCHEMBL8014120 | 0.86 | LTA4H (0.55) | ABL1BCRALDH1A1KDM4EMAPT | |
| SCHEMBL2344484 | 0.86 | LTA4H (0.55) | ABL1BCRALDH1A1KDM4EMAPT | |
| SCHEMBL14192249 | 0.84 | LTA4H (0.53) | ABL1BCRALDH1A1KDM4EMAPT | |
| SCHEMBL15591130 | 0.84 | LTA4H (0.53) | ABL1BCRALDH1A1KDM4EMAPT | |
| SCHEMBL10029848 | 0.84 | LTA4H (0.53) | ABL1BCRALDH1A1KDM4EMAPT | |
| SCHEMBL1310724 | 0.84 | ABL1 (0.60) | ABL1BCRALDH1A1KDM4EMAPT | |
| SCHEMBL14680785 | 0.82 | LTA4H (0.47) | ABL1BCRALDH1A1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9515268-B2 | Aromatic amine derivatives and preparation method, uses and organic electroluminescent devices thereof | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2016-12-06 | — | — | US | disclosed |
| US-9515268-B2 | Aromatic amine derivatives and preparation method, uses and organic electroluminescent devices thereof | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2016-12-06 | — | — | US | disclosed |
| US-20160087221-A1 | AROMATIC AMINE DERIVATIVES AND PREPARATION METHOD, USES AND ORGANIC ELECTROLUMINESCENT DEVICES THEREOF | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2016-03-24 | — | — | US | disclosed |
| US-20160087221-A1 | AROMATIC AMINE DERIVATIVES AND PREPARATION METHOD, USES AND ORGANIC ELECTROLUMINESCENT DEVICES THEREOF | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160087221-A1 | AROMATIC AMINE DERIVATIVES AND PREPARATION METHOD, USES AND ORGANIC ELECTROLUMINESCENT DEVICES THEREOF | C1S, C5, C9 | ABL1 644/4885BCR 561/4885ALDH1A1 709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.